AZN vs GATX · P/E 28, $288.38B cap vs P/E 19, rev $1.16B
AstraZeneca PLC (AZN) versus GATX Corporation (GATX) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
GATX Corporation (GATX) is a rental & leasing services company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported GATX revenue for 2026-06-30 was $1.16B. Net income was $188.9M. Revenue was up 99.4% from 2026-03-31 to 2026-06-30. GATX currently screens at market cap $6.23B and trailing P/E 18.8.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. GATX currently screens at market cap $6.23B and trailing P/E 18.8.
Not investment advice. Open the AZN and GATX stock pages for the full models.
Not investment advice.